Information  X 
Enter a valid email address
  Print      Mail a friend       More announcements

Monday 09 March, 2020

Societe Generale SA

Form 8.3 - Allergan plc

RNS Number : 4043F
Societe Generale SA
09 March 2020
 

  Ap19

 

 

FORM   8.3

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

 

1.  KEY   INFORMATION

 

Nameofpersondealing (Note 1)

Société Générale S.A.

Companydealtin

   Allergan plc

Classofrelevantsecuritytowhichthe dealingsbeingdisclosedrelate (Note 2)

US$0.0001 ordinary shares

Date of dealing

06/03/2020

 

2.  INTERESTS AND SHORT POSITIONS

 

(a)  Interests   and   short   positions   (following   dealing)   in   the   class   of   relevant   security   dealt   in   (Note 3)

 

 

Long

Short

Number

(%)

Number

(%)

(1) Relevant securities

2,276,085

0.69

56,450

0.02

(2) Derivatives (other than options)

88,000

0.03

1,495,757

0.45

(3) Options and agreements to purchase/sell

58,500

0.02

0

0.00

Total

*5,527,162

*1.68

1,552,207

0.47%

 

* Include the holding of 3,104,577 shares on borrow products

 

 

(b)  Interests and short positions in relevant securities of the company, other than the class dealt in  (Note 3)

 

Class of relevant security:

Long

Short

 

Number

(%)

Number

(%)

(1) Relevant securities

 

 

 

 

(2) Derivatives (other than options)

 

 

 

 

(3) Options and agreements to purchase/sell

 

 

 

 

Total

 

 

 

 

 

 

Ap20

 

 

1.  DEALINGS  (Note   4)

 

(a)  Purchases and sales

 

Purchase/sale

Number of relevant securities

Price per unit USD (Note 5)

Purchase

80

190.292

Purchase

100

189.76

Purchase

100

190.3

Purchase

99

191.75

Purchase

1

191.75

Purchase

5

190.58

Purchase

100

190.46

Purchase

100

190.68

Purchase

100

190.26

Purchase

100

189.76

Purchase

5

190.78

Purchase

100

190.22

Purchase

100

190.79

Purchase

100

190.61

Purchase

100

191.71

Purchase

51

191.95

Purchase

100

191.95

Purchase

41

191.95

Purchase

8

191.95

Purchase

755

191.95

Purchase

100

189.99

Purchase

6

189.64

Purchase

146

191.95

Purchase

300

191.95

Purchase

4,138

191.95

Purchase

7,289

191.95

Sale

100

188.9

Sale

100

189.51

Sale

99

191.52

Sale

100

190.82

Sale

1

191.52

Sale

2

190.88

Sale

50

189.3

Sale

30

191.34

Sale

50

189.3

Sale

50

191.43

Sale

50

191.43

Sale

1

191.3

Sale

100

191.1

Sale

99

191.31

Sale

5

191.4

Sale

95

191.4

Sale

100

191.52

Sale

38

189.6

Sale

95

190.27

Sale

100

191.57

Sale

100

191.78

Sale

7

191.53

Sale

100

191.04

Sale

62

189.6

Sale

100

189.26

Sale

100

189.25

Sale

15

189.67

Sale

100

191.04

Sale

100

189.62

Sale

100

191.92

Sale

15

189.67

Sale

34

189.67

Sale

100

189.56

Sale

93

191.53

Sale

100

191.16

Sale

100

189.86

Sale

10

190.52

Sale

90

190.52

Sale

100

191.31

Sale

50

189.47

Sale

50

189.47

Sale

100

189.56

Sale

100

190.86

Sale

100

189.03

Sale

100

190.15

Sale

100

190.27

Sale

100

189.76

Sale

100

190.11

Sale

100

190.12

Sale

200

191.95

Sale

400

191.95

Sale

100

191.95

Sale

100

191.95

Sale

100

189.25

Sale

2

191.46

Sale

2

191.46

Sale

92

191.46

Sale

100

191.45

Sale

2

191.46

Sale

2

191.46

Sale

100

192.22

Sale

100

189.44

Sale

198

189.27

Sale

352

189.27

Sale

20

189.27

Sale

24

189.27

Sale

100

191.74

Sale

100

191.05

Sale

8

190.81

Sale

92

190.81

Sale

92

191.06

Sale

8

191.06

Sale

100

191.03

Sale

100

191.74

Sale

1

189.47

Sale

100

191.72

Sale

5

189.47

Sale

34

189.62

Sale

23

189.62

Sale

35

189.62

Sale

8

189.62

Sale

100

191.91

Sale

100

191.01

Sale

100

191.5

Sale

100

191.5

Sale

100

188.91

Sale

100

191.3

Sale

100

190.64

Sale

100

190.74

Sale

100

189.15

Sale

50

189.17

Sale

50

189.18

Sale

100

190.28

Sale

100

190.42

Sale

100

190.35

Sale

100

190.32

Sale

100

191.64

Sale

100

191.47

Sale

100

190.93

Sale

100

190.28

Sale

100

190.17

Sale

100

191.09

Sale

100

191.36

Sale

100

189.13

Sale

100

189.11

Sale

100

189.14

Sale

100

191.53

Sale

100

191.36

Sale

100

190.61

Sale

100

188.97

Sale

5

191.09

Sale

95

191.09

Sale

100

190.27

Sale

100

189.7

Sale

100

191.06

Sale

18

191.84

Sale

6

191.84

Sale

19

191.84

Sale

10

191.84

Sale

26

191.84

Sale

200

190.57

Sale

5

189.75

Sale

1,966

191.95

Sale

1,726

191.95

Sale

200

190.75

Sale

1

190.64

Sale

99

190.22

Sale

100

189.78

Sale

100

191.14

Sale

100

189.73

Sale

100

189.95

Sale

100

190.48

Sale

100

188.94

Sale

100

190.08

Sale

100

189.37

Sale

68

189.27

Sale

32

189.27

Sale

5

189.95

Sale

3

189.97

Sale

7

189.97

Sale

100

189.98

Sale

25

190.98

Sale

75

190.98

Sale

100

188.91

Sale

100

191.52

Sale

100

190.14

Sale

100

191.4

Sale

100

190.14

Sale

100

190.4

Sale

100

190.94

Sale

100

190.19

Sale

56

191.14

Sale

44

191.14

Sale

100

191

Sale

100

190.2

Sale

100

191.36

Sale

100

189.65

Sale

100

189.63

Sale

100

191.68

Sale

100

189.71

Sale

100

189.9

Sale

100

191.05

Sale

100

191.41

Sale

100

189.7

Sale

55

190.7

Sale

100

190.7

Sale

45

190.7

Sale

35

189.27

Sale

100

189.55

Sale

100

191.35

Sale

4

191.06

Sale

96

191.06

Sale

100

189.9

Sale

4,138

191.95

Sale

300

191.95

Sale

20,685

191.95

Sale

5,516

191.95

Sale

146

191.95

Total Purchases

14,124

 

Total Sales

48,302

 

 

 

(b)  Derivatives transactions (other than options transactions)

 

Productname,

e.g. CFD

Natureoftransaction

(Note 6)

Numberofrelevantsecurities

(Note 7)

Priceperunit USD

(Note 5)

 

 

 

 

 

(c)  Options transactions in respect of existing relevant securities

 

 

(i)  Writing, selling, purchasing or varying

 

Productname,

e.g. call option

Writing, selling,purchasing,varyingetc.

Numberofsecurities towhichtheoptionrelates (Note 7)

Exercise price

Type, e.g.American,Europeanetc.

Expiry date

Optionmoney paid/receivedperunit (Note 5)

 

 

 

 

 

 

 

 

 

(ii)  Exercising

 

Productname,

e.g. call option

Numberofsecurities

Exercisepriceper unit (Note 5)

 

 

 

 

 

(d)  Other dealings (including transactions in respect of new securities) (Note 4)

 

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

 

Ap21

2.  OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

 

 

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any 

relevant securities to which any derivative referred to on this form is referenced. 

If none, this should be stated.

 

 

 

 

 

 

 

 

 

 

Is a Supplemental Form 8 attached?  (Note   9)     Yes

 

Dateofdisclosure

09/03/2020

Contact name

Société Générale - Disclosure team

Telephone number

+33 1 42 14 92 74

If aconnectedEFM,nameofofferee/offerorwithwhichconnected

 

If aconnectedEFM,statenatureofconnection (Note 10)

 

 

 

 

 

 

 

 

 

 

 

 

Ap23

 

SUPPLEMENTAL   FORM 8

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL 

ACT,   1997, TAKEOVER RULES, 2013

 

 

 

 

DETAILS   OF OPEN POSITIONS

 

(This   form   should   be   attached   to   Form   8.1(a)   & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)

 

OPEN POSITIONS  (Note   1)

 

 

 

Productname,

e.g. call option

Written, orpurchased

Numberofrelevant securitiestowhichtheoptionorderivativerelates

Exercise price (Note 2)

Type, e.g.American,Europeanetc.

Expiry date

Listed Put Option

Sale

40,000

175

American options

15/01/2021

Listed Put Option

Sale

18,500

190

American options

15/01/2021

 

 

Notes

 

1.  Where there are open option positions or open derivative positions (except for CFDs), full details should be given. 

          Full  details of any existing agreements to purchase or to sell must also be given on this form.

 

2.  For all prices and other monetary amounts, the currency must be stated.

 

For full details of disclosure requirements, see Rule 8 of the   Rules. If in doubt, consult the Panel.

 

 

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
ISESSESMUESSEID

a d v e r t i s e m e n t